VG LIFE SCIENCES INC. Research and Development Expense
VG LIFE SCIENCES INC. (BIOM) reported Research and Development Expense of $140.15 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2015-11-19
- VG LIFE SCIENCES INC. research and development expense for the quarter ending 2015-09-30 was $140.15K, a 58.76% decline year-over-year.
- VG LIFE SCIENCES INC. research and development expense for the quarter ending 2015-06-30 was $162.79K, a 27.45% decline year-over-year.
- VG LIFE SCIENCES INC. research and development expense for the quarter ending 2015-03-31 was $159.65K, a 61.21% decline year-over-year.
- VG LIFE SCIENCES INC. research and development expense for the quarter ending 2014-12-31 was -$110.16K, a 124.01% decline year-over-year.
- VG LIFE SCIENCES INC. research and development expense for fiscal 2014 was $865.70K, a 7.07% increase from fiscal 2013.
- VG LIFE SCIENCES INC. research and development expense for fiscal 2013 was $808.52K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 231 month | Research and Development Expense 234 month |
|---|---|---|---|---|---|---|
| 2015-09-30 | $140.15K 10-Q · filed 2015-11-19 | $302.94K derived: sum of 2 quarters · filed 2015-11-19 | $462.59K 10-Q · filed 2015-11-19 | $352.43K derived: sum of 4 quarters · filed 2015-11-19 | ||
| 2015-06-30 | $162.79K 10-Q · filed 2015-08-19 | $322.44K 10-Q · filed 2015-08-19 | $212.28K derived: sum of 3 quarters · filed 2015-08-19 | $552.16K derived: sum of 4 quarters · filed 2015-11-19 | ||
| 2015-03-31 | $159.65K 10-Q · filed 2015-05-20 | $49.49K derived: sum of 2 quarters · filed 2015-05-20 | $389.37K derived: sum of 3 quarters · filed 2015-11-19 | $613.74K derived: sum of 4 quarters · filed 2015-11-19 | ||
| 2014-12-31 | -$110.16K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $229.72K derived: sum of 2 quarters · filed 2015-11-19 | $454.10K derived: sum of 3 quarters · filed 2015-11-19 | $865.70K 10-K · filed 2015-04-15 | $18.86M 10-K · filed 2015-04-15 | |
| 2014-09-30 | $339.88K 10-Q · filed 2015-11-19 | $564.26K derived: sum of 2 quarters · filed 2015-11-19 | $975.86K 10-Q · filed 2015-11-19 | $1.43M derived: sum of 4 quarters · filed 2015-11-19 | $18.96M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $224.38K 10-Q · filed 2015-08-19 | $635.98K 10-Q · filed 2015-08-19 | $1.09M derived: sum of 3 quarters · filed 2015-08-19 | $1.40M derived: sum of 4 quarters · filed 2015-08-19 | ||
| 2014-03-31 | $411.61K 10-Q · filed 2015-05-20 | $870.49K derived: sum of 2 quarters · filed 2015-05-20 | $1.17M derived: sum of 3 quarters · filed 2015-05-20 | |||
| 2013-12-31 | $458.88K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $759.08K derived: sum of 2 quarters · filed 2015-04-15 | $808.52K 10-K · filed 2015-04-15 | |||
| 2013-09-30 | $300.20K 10-Q · filed 2014-11-13 | $349.64K 10-Q · filed 2014-11-13 |